Literature DB >> 20306192

Possible mistakes in prediction of bone maturation in fibular hemimelia by Moseley chart.

György Szoke1, William G Mackenzie, Gyula Domos, Sándor Berki, Sándor Kiss, J Richard Bowen.   

Abstract

The purpose of this study was to establish a nomogram in order to predict limb length discrepancies in children with unilateral fibular hemimelia more accurately. In 31 children with unilateral fibular hemimelia the femoral-tibial length and skeletal age were determined an average of seven times per case by sequential radiographs during growth. From the data, a skeletal age nomogram was developed which shows a steeply declining mean skeletal age pattern in unilateral fibular hemimelia (the slope in girls was -0.59 and in boys -0.64). This nomogram crosses the normal mean skeletal age line of the Moseley straight-line graph at 10.5 years in girls and at 12 years in boys, and continues to decline until maturity. The results demonstrate an abnormal skeletal maturation process in patients with unilateral fibular hemimelia. The consistently declining steep skeletal age nomogram in unilateral fibular hemimelia makes prediction of skeletal maturity and limb length discrepancy inaccurate by the standard predictive methods particularly when using early skeletal ages. The skeletal age nomogram from our data determines skeletal maturation in children with unilateral fibular hemimelia more accurately, and allows a correct prediction of limb length discrepancy.

Entities:  

Mesh:

Year:  2010        PMID: 20306192      PMCID: PMC3080506          DOI: 10.1007/s00264-010-0988-6

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  26 in total

1.  Multiplier method for predicting limb-length discrepancy.

Authors:  D Paley; A Bhave; J E Herzenberg; J R Bowen
Journal:  J Bone Joint Surg Am       Date:  2000-10       Impact factor: 5.284

2.  Growth and predictions of growth in the lower extremities.

Authors:  M ANDERSON; W T GREEN; M B MESSNER
Journal:  J Bone Joint Surg Am       Date:  1963-01       Impact factor: 5.284

3.  Clinical validation of the multiplier method for predicting limb length at maturity, part I.

Authors:  Julyn A Aguilar; Dror Paley; Jonathan Paley; Shivkumar Santpure; Minoo Patel; Anil Bhave; John E Herzenberg
Journal:  J Pediatr Orthop       Date:  2005 Mar-Apr       Impact factor: 2.324

4.  Results of screw epiphysiodesis for the treatment of limb length discrepancy and angular deformity.

Authors:  Joseph G Khoury; Joao O Tavares; Sharon McConnell; Gregory Zeiders; James O Sanders
Journal:  J Pediatr Orthop       Date:  2007-09       Impact factor: 2.324

5.  Prospective evaluation of fifty-three consecutive percutaneous epiphysiodeses of the distal femur and proximal tibia and fibula.

Authors:  R W Timperlake; J R Bowen; J T Guille; I H Choi
Journal:  J Pediatr Orthop       Date:  1991 May-Jun       Impact factor: 2.324

6.  A graphic method for timing the correction of leg-length discrepancy.

Authors:  D M Eastwood; W G Cole
Journal:  J Bone Joint Surg Br       Date:  1995-09

7.  Developmental patterns in lower-extremity length discrepancies.

Authors:  F Shapiro
Journal:  J Bone Joint Surg Am       Date:  1982-06       Impact factor: 5.284

8.  A simple calculation for the timing of epiphysial arrest: a further report.

Authors:  R N Westh; M B Menelaus
Journal:  J Bone Joint Surg Br       Date:  1981-02

9.  Timing of physiodesis in limb length inequality. The Straight Line Graph applied in 30 patients.

Authors:  H I Lampe; B A Swierstra; A F Diepstraten
Journal:  Acta Orthop Scand       Date:  1992-12

10.  Equalization of lower limbs by epiphysiodesis: results of treatment.

Authors:  S Porat; A Peyser; G C Robin
Journal:  J Pediatr Orthop       Date:  1991 Jul-Aug       Impact factor: 2.324

View more
  1 in total

1.  Prevention of recurrence of tibia and ankle deformities after bone lengthening in children with type II fibular hemimelia.

Authors:  Arnold Popkov; Anna Aranovich; Dmitry Popkov
Journal:  Int Orthop       Date:  2015-04-02       Impact factor: 3.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.